A method for determining the biological activity of defibrotide

Details for Australian Patent Application No. 2002360945 (hide)

Owner Gentium Spa

Inventors Porta, Roberto; Cattaneo, Franco; Ferro, Laura

Agent Griffith Hack

Pub. Number AU-B-2002360945

PCT Number PCT/EP02/13371

PCT Pub. Number WO2003/052130

Priority 01830770.2 17.12.01 EP

Filing date 27 November 2002

Wipo publication date 30 June 2003

Acceptance publication date 8 November 2007

International Classifications

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

C12Q 1/56 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 01830770.2 17.12.01 EP

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002360945

8 July 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Jun 2004

8 November 2007 Application Accepted

  Published as AU-B-2002360945

6 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360946-USE OF T-CELL IMMUNE RESPONSE CDNA 7 (TIRC7) IN ANGIOGENIC AND ANTI-ANGIOGENIC THERAPY

2002360944-SYSTEM AND METHOD FOR FAIR, CHANNEL-DEPENDENT SCHEDULING FOR WIRELESS SYSTEMS